Alzheimer's disease

Biogen and Eisai move forward with investigational Alzheimer's therapy
Biopharma Reporter
Mon, 01/3/22 - 10:45 pm
Biogen
Eisai
lecanemab
Alzheimer's disease
fast track
FDA
Biogen-Eisai's potential Aduhelm sequel drug granted speedy review by FDA
Fierce Biotech
Tue, 12/28/21 - 10:55 am
Biogen
Eisai
lecanemab
FDA
Aduhelm
fast track
Alzheimer's disease
2022 forecast: How marketers must learn from Biogen's marketing struggles with Aduhelm
Fierce Pharma
Mon, 12/27/21 - 11:10 am
Biogen
Aduhelm
pharma marketing
Alzheimer's disease
Roche
Eli Lilly
What’s Behind Biogen’s Move To Cut Prices On Its Controversial Alzheimer’s Drug Aduhelm?
Forbes
Sun, 12/26/21 - 11:16 pm
Biogen
Aduhelm
drug pricing
Alzheimer's disease
Biogen, Eisai face down another Aduhelm refusal—this time from Japanese regulators
Fierce Pharma
Wed, 12/22/21 - 11:06 am
Biogen
Eisai
Aduhelm
Japan
Alzheimer's disease
Alzheimer's experts call on FDA to pull Biogen's Aduhelm
Endpoints
Tue, 12/21/21 - 10:31 am
Biogen
Aduhelm
FDA
Alzheimer's disease
Biogen halves Aduhelm's price and plots cost cuts as Medicare decision on controversial Alzheimer's drug nears
Fierce Pharma
Mon, 12/20/21 - 11:11 am
Biogen
Aduhelm
Alzheimer's disease
drug pricing
layoffs
Eli Lilly enters strike mode ahead of pivotal Alzheimer's, diabetes launches, CFO says
Fierce Pharma
Mon, 12/20/21 - 11:04 am
Eli Lilly
Alzheimer's disease
diabetes
donanemab
tirzepatide
Biogen’s Alzheimer’s drug Aduhelm is rejected by EU advisors
Pharmaforum
Fri, 12/17/21 - 11:11 am
Biogen
Aduhelm
Europe
Alzheimer's disease
Biogen hits the gas pedal on Aduhelm confirmatory trial, hoping to deliver results in 2026
Fierce Pharma
Thu, 12/16/21 - 12:09 pm
Biogen
Aduhelm
FDA
clinical trials
Alzheimer's disease
Large Study Indicates Viagra Might Reduce Alzheimer's Risk
BioSpace
Mon, 12/6/21 - 11:52 pm
Viagra
sildenafil
Alzheimer's disease
Research Roundup: A Potential Cause of Alzheimer’s Disease and More
BioSpace
Fri, 12/3/21 - 10:52 am
R&D
Alzheimer's disease
ALS
Lyme disease
'What it takes': As Lilly's Alzheimer's drug approaches FDA, launch leader feels 'amplified' sense of excitement
Fierce Biotech
Tue, 11/30/21 - 10:25 am
Eli Lilly
donanemab
Alzheimer's disease
Could Roche Put a Crinkle in Biogen's Alzheimer's Drug Launch?
Motley Fool
Sun, 11/28/21 - 11:03 pm
Roche
Biogen
Alzheimer's disease
Aduhelm
gantenerumab
Study: Biogen’s Aduhelm Caused Brain Swelling in Over One-Third of Study Participants
BioSpace
Mon, 11/22/21 - 10:31 pm
Biogen
Aduhelm
brain swelling
ARIA-edema
Alzheimer's disease
Biogen seeking more information in investigation of Aduhelm patient's death
BioPharma Dive
Sat, 11/20/21 - 11:58 am
Biogen
Aduhelm
patient deaths
Alzheimer's disease
Major Insurers Weigh in on “Medical Necessity” of Biogen’s Aduhelm
BioSpace
Sat, 11/20/21 - 11:57 am
Biogen
Aduhelm
insurers
Alzheimer's disease
Biogen's Aduhelm 'likely' linked to Alzheimer's patient's death, RBC analyst says
Fierce Pharma
Thu, 11/18/21 - 10:58 pm
Biogen
Aduhelm
Alzheimer's disease
patient deaths
EU steers clear of Aduhelm as a bigger headache threatens
EP Vantage
Thu, 11/18/21 - 10:33 am
Europe
Biogen
Aduhelm
CHMP
Alzheimer's disease
Medicare
Biogen’s Aduhelm, already battling US skepticism, faces likely European rejection
Fierce Pharma
Wed, 11/17/21 - 10:53 am
Biogen
Europe
Aduhelm
Alzheimer's disease

Pages